spinal muscular atrophy: Spinal muscular atrophy is a disorder of spinal motor neurons characterized clinically by the development of muscle weakness and atrophy.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
294 |
4. Check minimum number of eventsNone |
294 |
5. Include endpointsNone |
294 |
6. Filter based on genotype QC (FinnGen only) |
294 |
Control definitions (FinnGen only)
- Control exclude
- G6_NEUATR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified spinal muscular atrophies
based on the number of shared cases.
Similar with more cases:
- Systemic atrophies primarily affecting the central nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3434 | 1501 | 1850 |
| Only index persons | 1766 | 795 | 971 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.04 | 0.05 |
| Only index persons | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 60.57 | 61.22 | 59.94 |
| Only index persons | 56.32 | 57.03 | 55.75 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 294 | 112 | 182 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.08 |
| Median age at first event (years) | 59.86 | 55.49 | 62.55 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 272
- Matched controls
- 2720
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G12.9
ICD-10 Finland
Spinal muscular atrophy, unspecified
+∞
143.9
125
*
G12.8
ICD-10 Finland
Other spinal muscular atrophies and related syndromes
+∞
94.4
85
*
G12.2
ICD-10 Finland
Motor neuron disease
+∞
65.3
60
*
34899
ICD-8 Finland
Motor neurone disease, Other and unspecified manifestations
+∞
26.5
25
*
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
+∞
24.3
23
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
13.2
23.1
41
36
N03AE01
ATC
clonazepam; systemic
8.4
22.2
51
73
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.2
18.9
54
105
G72.9
ICD-10 Finland
Myopathy, unspecified
35.7
18.3
23
7
TAB00
NOMESCO Finland
Lumbar puncture
9.9
17.8
36
41
N99
ICPC
Neurological disease other
17.0
14.2
22
14
N07XX02
ATC
riluzole; oral
+∞
12.6
12
*
3352A
ICD-9 Finland
Anterior horn cell disease, Motor neuron disease[SCLEROSIS LATERALIS AMYOTROPHICA]
+∞
11.5
11
*
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
29.4
10.8
14
5
R1250
NOMESCO Finland
Evaluation of functional capability
12.0
10.2
18
16
N03AX12
ATC
gabapentin; oral
3.3
10.0
54
189
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.3
9.7
36
93
L28
ICPC
Limited function/disability (L)
2.9
9.6
64
261
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
+∞
9.4
9
*
3351X
ICD-9 Finland
Anterior horn cell disease, Spinal muscular atrophy[ATROPHIA MUSCULORUM SPINALIS NUD]
+∞
9.4
9
*
34898
ICD-8 Finland
Motor neurone disease, Alii definiti
+∞
9.4
9
*
G13.0
ICD-10 Finland
Paraneoplastic neuromyopathy and neuropathy
+∞
9.4
9
*
N28
ICPC
Limited function/disability (N)
10.1
9.4
18
19
M03BX01
ATC
baclofen; systemic
9.9
8.4
16
17
J96.1
ICD-10 Finland
Chronic respiratory failure
7.2
8.2
19
28
R47.1
ICD-10 Finland
Dysarthria and anarthria
12.2
8.2
14
12
N29
ICPC
Neurological sympt/complt other
9.4
8.2
16
18
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
46.3
7.8
9
*
NXL00
NOMESCO Finland
Biopsy of muscle
25.8
7.6
10
*
Z50.1
ICD-10 Finland
Other physical therapy
4.6
7.6
25
58
G71.08
ICD-10 Finland
Other muscular dystrophy
82.2
7.5
8
*
M62.5
ICD-10 Finland
Muscle wasting and atrophy, not elsewhere classified
82.2
7.5
8
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
7.4
58
258
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
+∞
7.3
7
*
SPAT1229
SPAT
Assessment of need for aid
3.2
7.1
37
128
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.9
6.9
27
74
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
7.5
6.8
15
21
R25.3
ICD-10 Finland
Fasciculation
41.1
6.8
8
*
R13
ICD-10 Finland
Dysphagia
3.5
6.4
29
90
G13.2*E03.9
ICD-10 Finland
Systemic atrophy primarily affecting central nervous system in myxoedema
+∞
6.3
6
*
G12.0
ICD-10 Finland
Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
42
147
3.17
9.64
2.4
2.4
—
4.6
—
0
6
(4027681)
12
15
8.30
8.92
1.4
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
10
11
9.38
8.13
1.3
1.0
mmol/l
1.9
1.8
—
10
11
(1616796) Gas panel - Central venous blood
20
47
4.49
8.07
4.1
4.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
24
5.62
6.83
1.2
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
22
5.64
6.34
1.2
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
43
4.13
6.26
1.6
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
27
4.99
6.03
1.2
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
6
13.65
5.10
1.1
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
5
14.29
4.59
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
5
14.29
4.59
1.1
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
15
49
3.17
3.86
2.9
2.2
%
17.9
15.7
—
10
25
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
16
5.76
3.68
1.3
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
33
169
2.07
3.45
4.2
3.5
ph
7.4
7.4
—
5
17
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
42
3.19
3.41
1.2
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
18
5.12
3.39
1.3
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
192
2200
0.63
3.30
4.9
5.2
mmol/l
2.7
2.7
0.75
169
2009
(3004588) Protein electrophoresis panel - Serum or Plasma
33
175
2.00
3.15
2.3
2.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
8
7.63
3.07
1.3
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
51
2.83
3.03
3.4
2.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
177
2047
0.66
2.95
7.5
6.2
mmol/mol
40.1
40.7
0.37
159
1894
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
13
5.49
2.88
3.3
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
9
6.78
2.88
1.3
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
221
2436
0.63
2.87
28.8
22.9
e9/l
6.9
6.8
0.32
215
2357
(3026361) Erythrocytes [#/volume] in Blood
221
2436
0.63
2.87
28.8
22.8
e12/l
4.4
4.5
0.26
216
2356
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
189
2152
0.66
2.85
4.5
4.6
mmol/l
4.6
4.5
0.95
169
1981
(3026782) Osmolality of Urine
70
480
1.60
2.82
4.9
2.9
mosm/kgh2o
571.7
559.9
0.16
59
408
(3037522) Nuclear Ab [Titer] in Serum
44
267
1.76
2.80
1.4
1.3
titre
420.0
470.0
—
8
60
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
6
8.45
2.76
1.4
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
6
8.45
2.76
1.4
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
6
8.45
2.76
1.4
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
188
2136
0.67
2.71
4.4
4.6
mmol/l
1.5
1.4
0.37
166
1950
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
10
6.10
2.71
1.3
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
129
1572
0.68
2.68
3.9
4.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
22
107
2.14
2.65
2.4
3.2
%
1.1
1.2
0.23
22
107
(3009508) Creatinine [Moles/volume] in Urine
49
730
0.61
2.64
3.3
3.2
mmol/l
6.8
7.6
0.77
37
610
(3022313) Gas panel - Capillary blood
24
123
2.04
2.54
3.9
3.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
39
609
0.59
2.52
1.6
1.7
mmol/l
1.3
1.3
0.35
32
511
(3028626) Oxygen [Partial pressure] in Capillary blood
16
70
2.36
2.46
3.2
3.1
kpa
8.6
8.2
0.39
16
60
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
58
818
0.64
2.44
4.1
4.6
%
24.6
21.7
0.81
37
409
(3000850) Epithelial cells [#/volume] in Urine
70
497
1.54
2.41
4.0
2.7
e6/l
6.8
4.7
0.41
62
436
(3024354) Oxygen [Partial pressure] in Venous blood
31
178
1.83
2.37
2.6
3.7
kpa
4.4
4.4
0.07
31
170
(3030467) Casts [#/volume] in Urine by Automated count
87
650
1.48
2.35
4.9
3.3
e6/l
0.2
0.5
1.65
77
488
(3012516) Albumin [Mass/volume] in Urine
48
699
0.63
2.31
3.5
3.2
mg/l
1201.8
329.5
0.33
33
459
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
191
2142
0.69
2.30
5.1
4.8
mmol/l
5.9
6.0
1.10
173
1948
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
47
2.62
2.30
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
183
2064
0.70
2.24
4.2
4.1
mmol/l
1.4
1.3
0.74
163
1871
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
107
842
1.43
2.18
5.3
3.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
391
1.53
2.07
3.7
3.0
e6/l
1.0
1.0
0.09
44
231
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
51
2.41
1.97
1.6
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
34
213
1.67
1.96
3.1
4.6
mmol/l
3.1
1.8
1.22
28
167
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
107
856
1.39
1.95
5.3
3.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
11
4.60
1.95
1.0
1.6
nmol/l
141.4
127.7
—
5
11
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
16
3.80
1.94
1.0
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
34
214
1.67
1.93
3.1
4.6
kpa
6.0
5.7
0.91
34
207
(3012544) pH of Venous blood
35
224
1.64
1.87
3.1
4.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
12
4.22
1.83
1.0
3.3
umol/l
29.4
30.0
—
5
12
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
109
1.90
1.82
1.1
1.2
iu/ml
63.9
129.4
—
5
44
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
186
2062
0.73
1.75
18.7
14.6
ml/min/173m2
86.6
77.8
4.20
168
1711
(3026389) Candida sp identified in Specimen by Organism specific culture
7
24
2.96
1.73
1.3
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
25
2.84
1.66
2.0
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
128
1076
1.34
1.65
7.1
5.0
estimate
0.0
0.0
0.00
28
220
(1761482) Bacteria [#/volume] in Urine by Culture
14
70
2.05
1.62
4.2
5.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
106
869
1.34
1.61
2.4
2.2
nmol/l
81.1
77.4
0.67
95
770
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
161
1.67
1.59
1.6
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
20
3.04
1.59
1.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
79
620
1.37
1.58
4.4
3.3
—
—
—
0
0
(4034850)
15
78
1.97
1.57
10.3
11.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
67
513
1.40
1.55
1.8
1.8
pmol/l
511.5
22717065.9
0.79
59
427
(3020682) Albumin/Creatinine [Ratio] in Urine
56
735
0.71
1.55
5.1
3.9
mg/mmol
2.9
8.2
3.30
38
473
(3019230) Fractional oxyhemoglobin in Venous blood
8
33
2.46
1.55
1.4
2.6
%
58.8
58.9
—
8
33
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
43
0.00
1.53
0.0
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
84
669
1.36
1.53
3.6
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
129
1095
1.32
1.53
5.1
3.8
estimate
0.0
0.0
0.00
26
206
(3035637) Corticotropin [Mass/volume] in Plasma
6
21
2.89
1.51
1.8
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
134
1150
1.30
1.44
8.3
7.1
mmol/l
1.2
1.2
0.15
106
962
(3011412) CD3 cells [#/volume] in Blood
6
22
2.76
1.44
3.7
1.7
e9/l
1.4
0.8
—
6
8
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
174
1.61
1.43
4.0
2.7
ml/min/173m2
99.9
61.7
0.39
13
74
(3035350) Ketones [Presence] in Urine by Test strip
126
1074
1.30
1.42
4.9
3.8
estimate
0.0
0.0
0.00
28
219
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
162
0.48
1.40
1.8
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
23
2.64
1.37
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
147
0.46
1.36
1.0
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
214
2296
0.75
1.35
19.4
14.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
153
1.62
1.33
5.5
2.7
e9/l
3.7
3.8
0.12
17
117
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
24
2.53
1.31
1.0
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
98
816
1.30
1.30
5.8
4.0
e6/l
49.8
93.2
0.83
85
595
(3019309) Folate [Moles/volume] in Red Blood Cells
60
465
1.36
1.29
1.8
1.7
nmol/l
1249.6
1202.1
0.14
53
349
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
18
2.81
1.29
1.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
18
2.81
1.29
1.4
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
160
0.49
1.28
1.1
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
35
2.32
1.28
3.0
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
107
1247
0.78
1.27
2.4
2.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
83
685
1.29
1.17
4.5
4.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
111
0.44
1.15
3.6
2.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
62
492
1.33
1.15
5.0
4.1
kg/l
1.0
1.0
0.03
14
65
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
30
2.36
1.13
1.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
30
2.36
1.13
2.0
1.8
ug/l
10.6
16.9
—
7
30
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
66
1.85
1.10
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
15
89
1.72
1.10
5.7
4.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
21
2.40
1.09
4.0
3.6
u/ml
28.8
63.3
—
5
21
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
21
2.40
1.09
1.4
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
74
607
1.29
1.09
5.1
3.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
87
1024
0.79
1.09
5.3
5.3
ug/l
28.0
2.9
0.93
82
898
(3021788) Differential panel - Synovial fluid
7
32
2.22
1.09
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
46
588
0.74
1.06
3.1
3.1
ug/l
0.9
0.8
0.95
32
392
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
373
1.34
1.03
4.6
3.2
e6/l
1.9
1.7
0.08
36
215
(3002582) Erythrocytes [#/volume] in Urine
85
715
1.27
1.02
5.6
3.5
e6/l
38.3
155.7
0.70
75
557
(3000330) Specific gravity of Urine by Test strip
18
115
1.60
1.02
5.3
4.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
54
1.88
0.98
2.2
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
36
1.97
0.97
1.3
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
50
1.82
0.97
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
181
1953
0.81
0.97
18.0
16.9
%
38.0
39.6
0.87
105
1341
(3002256) Pathology report gross observation
20
291
0.66
0.97
1.4
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
51
1.79
0.95
1.1
1.1
—
14.4
—
0
6
(3017181) Myelocytes/100 leukocytes in Blood
28
203
1.42
0.91
4.8
4.6
%
1.8
0.8
0.54
11
71
(3021440) Promyelocytes/100 leukocytes in Blood
26
187
1.43
0.89
4.9
4.8
%
0.4
0.1
—
10
63
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
31
1.95
0.85
2.8
4.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
210
2219
0.81
0.84
20.5
15.7
mg/l
26.1
24.5
0.22
181
1787
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
340
1.31
0.84
1.3
1.3
u/ml
1.0
13.9
2.31
18
134
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.1
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
26
0.00
0.79
0.0
3.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
34
1.78
0.76
1.0
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
149
1362
1.19
0.76
5.3
5.1
mmol/l
6.6
6.8
0.93
137
1270
(3018418) pH of Serum or Plasma
80
690
1.22
0.76
4.7
4.0
ph
7.4
7.4
0.27
20
133
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
242
0.68
0.76
1.1
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
133
1206
1.19
0.74
5.2
6.6
umol/l
11.9
11.8
0.01
125
1139
(3007853) Bacteria identified in Skin by Aerobe culture
34
265
1.32
0.74
2.6
1.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
38
1.86
0.74
2.4
3.1
mmol/l
3.9
4.1
—
7
38
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
38
1.86
0.74
2.4
3.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
38
1.86
0.74
2.4
3.1
mmol/l
108.7
105.0
—
7
38
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
21
285
0.72
0.73
8.3
7.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
109
973
1.19
0.72
12.9
9.7
inr
1.3
1.2
0.03
30
276
(3021589) Normoblasts [#/volume] in Blood
108
965
1.19
0.71
10.5
10.3
e9/l
0.0
0.0
0.42
98
801
(3024928) Oxygen saturation in Venous blood
7
41
1.72
0.70
1.3
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
57
481
1.23
0.67
6.1
5.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
95
0.52
0.67
1.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
42
342
1.27
0.67
1.4
1.3
iu/ml
28.8
38.4
0.31
11
110
(3022806) Fractional oxyhemoglobin in Capillary blood
5
28
1.80
0.66
2.2
1.3
%
85.8
89.3
—
5
28
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
44
1.61
0.65
1.1
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
30
235
1.31
0.64
1.9
2.6
e9/l
73.0
67.6
0.40
24
189
(3044941) Cell count panel - Synovial fluid
5
29
1.74
0.64
1.8
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
20
147
1.39
0.63
1.8
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
49
1.65
0.62
1.1
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
63
1.61
0.62
1.1
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
30
1.68
0.61
1.4
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
25
192
1.33
0.61
5.4
8.3
—
—
—
0
0
(4035726)
26
201
1.32
0.61
1.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
51
1.58
0.61
5.8
5.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
162
0.67
0.60
1.3
2.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
35
1.73
0.58
1.0
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
70
613
1.19
0.57
5.6
4.0
estimate
0.0
0.0
0.00
28
209
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
122
0.65
0.56
1.3
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
37
1.63
0.56
7.0
2.3
e9/l
4.2
5.0
—
6
37
(3026493) Urate [Moles/volume] in Serum or Plasma
70
615
1.18
0.55
3.6
2.8
umol/l
10618.7
8032.4
0.13
62
518
(3025159) Blasts/100 leukocytes in Blood
23
178
1.32
0.55
4.3
4.9
%
0.0
0.2
—
7
55
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
259
0.76
0.54
1.3
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
6
39
1.55
0.53
6.3
2.9
%
0.8
1.3
—
6
29
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
39
1.55
0.53
8.5
2.9
%
62.8
58.7
—
6
39
(46235355) HIV 1 and 2 tests - Meaningful Use set
24
302
0.78
0.53
1.3
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
302
0.78
0.53
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
51
439
1.20
0.51
2.4
3.1
mmol/l
2.4
2.4
0.24
46
378
(40761535) Cells panel - Urine sediment
23
181
1.29
0.50
4.0
3.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
169
1596
1.14
0.49
4.2
3.7
pmol/l
15.1
14.8
0.91
159
1418
(3013512) EKG study
81
728
1.16
0.49
4.9
4.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
126
1168
1.14
0.49
6.9
5.9
e9/l
0.2
0.2
0.18
119
1041
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
46
1.53
0.48
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
46
1.53
0.48
1.4
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
46
1.53
0.48
1.1
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
246
1.24
0.48
5.4
3.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
112
1.36
0.45
1.3
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
295
0.80
0.45
4.8
4.7
%
30.8
31.6
0.13
18
199
(40758558) Short blood count panel - Blood
61
541
1.16
0.44
6.8
7.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
31
1.62
0.43
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.4
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.4
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
1.4
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
32
1.57
0.42
1.2
2.0
pg
35.4
34.3
—
5
32
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
70
1.44
0.42
1.3
2.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
19
238
0.78
0.42
12.3
9.4
g/l
126.5
120.7
0.48
19
233
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
59
1.37
0.41
1.1
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
59
1.37
0.41
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
16
0.00
0.41
0.0
3.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
106
1.34
0.40
2.0
2.4
g/l
3.7
3.7
—
9
77
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
106
1.34
0.40
2.0
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
106
1.34
0.40
2.0
2.4
g/l
7.7
7.4
—
9
81
(3042631) Mycobacterium sp identified in Specimen
5
35
1.44
0.39
1.0
2.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
89
1.36
0.38
2.3
1.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
36
1.40
0.38
2.6
3.3
u/ml
82.8
35.4
—
5
36
(3000494) Fungus identified in Specimen by Culture
22
267
0.81
0.38
1.5
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
42
1.44
0.35
1.2
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
82
754
1.12
0.35
5.9
5.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
101
941
1.11
0.35
2.1
2.0
pmol/l
93.9
95.0
0.07
53
496
(40761536) Microorganisms panel - Urine sediment
23
191
1.22
0.34
4.4
3.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
87
0.68
0.33
1.2
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
21
252
0.82
0.33
1.2
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
92
1.32
0.32
2.4
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
53
1.33
0.31
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
141
0.77
0.30
1.4
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
56
1.26
0.29
1.9
2.1
mg/l
9.7
13.1
—
7
51
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
102
959
1.10
0.29
4.0
3.9
ng/l
92.9
44.9
0.54
80
698
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
44
395
1.13
0.28
2.2
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
62
1.30
0.28
1.0
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
618
1.11
0.28
2.2
2.1
mg/l
3.3
3.1
0.24
56
535
(3007164) IgA [Mass/volume] in Serum or Plasma
47
425
1.13
0.27
1.4
1.4
g/l
2.6
2.6
0.10
36
253
(3003694) ABO and Rh group [Type] in Blood
50
548
0.89
0.27
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
5
73
0.68
0.26
6.0
2.5
u/ml
0.4
0.3
—
5
35
(3008898) HLA-B27 [Presence]
9
72
1.26
0.26
1.0
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
118
1126
1.08
0.24
6.4
5.7
e9/l
0.6
0.6
0.49
110
988
(3011397) Hemoglobin [Presence] in Urine by Test strip
53
488
1.10
0.23
4.6
3.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
35
387
0.89
0.22
2.1
2.0
s
29.7
29.2
0.33
35
377
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
110
1050
1.08
0.22
8.0
6.2
mmol/l
1.2
1.2
0.50
102
939
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
107
1021
1.08
0.21
4.7
4.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
11
0.00
0.21
0.0
1.1
—
3.8
—
0
11
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(44813793)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
216.2
—
0
10
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
8.1
—
0.6
—
0
12
(3019198) Lymphocytes [#/volume] in Blood
120
1151
1.07
0.21
6.7
5.9
e9/l
1.7
2.0
1.08
111
1029
(3035320) C reactive protein [Mass/volume] in Body fluid
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
118
1132
1.07
0.20
6.5
5.7
e9/l
0.0
0.0
0.60
110
1000
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
48
1.26
0.20
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
48
1.26
0.20
1.2
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
1.1
—
0
14
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
11.2
—
0
5
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
49
1.23
0.20
1.3
1.2
u/l
10.0
8.4
—
6
37
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
154
0.84
0.19
1.2
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
42
454
0.91
0.18
3.1
3.8
ng/l
69.5
268.9
1.39
31
362
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.7
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
1.7
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
71
749
0.93
0.17
3.5
3.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
79
751
1.07
0.17
2.8
3.4
mmol/l
2.3
2.3
0.24
74
655
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
66
0.75
0.17
1.0
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
74
703
1.07
0.17
2.6
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
195
1989
0.94
0.16
5.1
4.5
mu/l
1.8
2.0
1.07
182
1784
(3021960) Folate [Moles/volume] in Serum or Plasma
62
588
1.07
0.15
1.7
1.6
nmol/l
17.9
20.4
0.86
56
495
(36660697) Celiac disease serology panel - Serum
19
170
1.13
0.14
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
201
0.89
0.14
1.7
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
51
483
1.07
0.13
1.8
1.8
mg/l
1.9
1.5
0.19
41
384
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
50
527
0.94
0.12
2.4
2.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
134
1308
1.04
0.12
9.2
9.5
e9/l
4.4
4.1
0.41
125
1155
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
250
1.09
0.11
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
157
0.89
0.11
3.3
2.5
—
—
—
0
0
(3019225) pH of Specimen
21
229
0.91
0.11
5.0
3.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.8
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
87
1.15
0.09
1.6
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
106
1034
1.04
0.09
7.2
5.9
%
0.6
0.6
0.25
101
971
(3037467) Urinalysis macro (dipstick) panel - Urine
155
1524
1.04
0.09
5.5
4.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
85
873
0.96
0.08
2.3
2.1
—
—
—
0
0
(3000492) Spirometry study
21
195
1.08
0.08
1.8
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
88
1.14
0.08
2.8
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
71
0.84
0.07
3.7
3.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
20
186
1.08
0.07
3.5
4.5
%
3.1
0.4
—
7
51
(3025941) Bacteria identified in Stool by Culture
13
118
1.11
0.07
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
275
1.06
0.07
2.0
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
47
453
1.04
0.07
1.2
1.2
u/ml
0.8
1.0
0.45
15
114
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
142
1441
0.97
0.06
3.2
3.2
u/l
52.5
51.3
0.04
129
1339
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
104
0.86
0.06
1.6
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
296
1.05
0.06
1.2
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
131
0.91
0.05
13.8
12.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
12
110
1.09
0.05
9.8
9.3
%
1.5
1.6
0.18
12
105
(3001122) Ferritin [Mass/volume] in Serum or Plasma
92
935
0.98
0.04
3.1
2.7
ug/l
299.4
145.6
0.94
84
855
(3019060) Gas panel - Arterial blood
18
170
1.06
0.04
10.5
7.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
29
280
1.04
0.03
9.0
8.6
mmol/l
3.1
1.2
1.58
21
221
(3042936) Bacteria identified in Isolate by Culture
34
350
0.97
0.03
2.4
2.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
105
1062
0.98
0.03
7.4
5.9
%
2.6
2.9
0.68
100
997
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
127
0.94
0.01
2.4
2.4
—
—
—
0
0
(4010399)
17
164
1.04
0.00
1.4
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
12
122
0.98
0.00
1.3
1.8
g/l
1.8
1.5
0.53
12
110
(3005322) IgE [Units/volume] in Serum or Plasma
12
119
1.01
0.00
1.1
1.2
u/ml
821.1
172.5
0.93
12
106
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
141
0.99
0.00
2.4
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
28
281
1.00
0.00
2.0
3.2
umol/l
5.1
8.7
2.31
22
251
(3013707) Erythrocyte sedimentation rate by Westergren method
168
1679
1.00
0.00
5.0
4.0
mm/h
13.5
13.2
0.09
153
1526
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
74
744
0.99
0.00
3.0
3.2
ng/l
1841.5
1499.0
0.23
62
634
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
276
1.02
0.00
2.1
2.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
12.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
53
0.94
0.00
1.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
49
1.02
0.00
1.8
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
98.8
—
0
5
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
63
0.95
0.00
1.3
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
12.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(44806420)
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
65
0.92
0.00
1.7
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.2
—
12496.2
—
0
6
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
66
0.91
0.00
1.7
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(4094501)
5
59
0.84
0.00
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
65
0.92
0.00
1.7
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
70
1.00
0.00
1.3
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
12.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_SPINAMUSCOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_SPINAMUSCOTH | 5.729 [4.42, 7.42] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.129 |
During the follow-up period (1.1.1998 — 31.12.2019), 309 out of 670 females with G6_SPINAMUSCOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_SPINAMUSCOTH | 3.826 [3.06, 4.79] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 340 out of 805 males with G6_SPINAMUSCOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_SPINAMUSCOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.497% | 0.723% |
| 5 | 3.225% | 3.906% |
| 10 | 6.97% | 10.02% |
| 15 | 14.373% | 18.355% |
| 20 | 23.91% | 30.396% |
Relationships between endpoints
↥Index endpoint: G6_SPINAMUSCOTH – Other and unspecified spinal muscular atrophies
GWS hits: 9
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data